VP6-2021: IMpassion050: A phase III study of neoadjuvant atezolizumab + pertuzumab + trastuzumab + chemotherapy (neoadj A + PH + CT) in high-risk, HER2-positive early breast cancer (EBC)

Jens Huober, Carlos H. Barrios, Naoki Niikura, Michał Jarząb, Y-C Chang, Shannon Leigh Huggins-Puhalla, Vilma Graupner, Daniel Eiger, Volkmar Henschel, N Gochitashvili, Chiara Lambertini, Eleonora Restuccia, H. Zhang